Literature DB >> 32796465

Single-level Posterolateral Fusion (PLF) Alone and Posterior Interbody Fusion (PLIF/TLIF) Alone Lead to a Decreased Risk of Short-term Complications Compared to Combined PLF With PLIF/TLIF Procedures: A Matched Analysis.

Mark A Plantz1, Wellington K Hsu.   

Abstract

STUDY
DESIGN: Retrospective review of a database cohort.
OBJECTIVE: To compare short-term outcome measures and complications between single-level posterolateral fusion (PLF), single-level posterior interbody fusion (PLIF/TLIF), and combined single-level PLF+PLIF/TLIF. SUMMARY OF BACKGROUND DATA: Both PLF and interbody fusion are well-established procedures for degenerative spinal disease. However, there is lack of consensus as to the ideal surgical approach for specific applications. Additionally, the difference in risk of complications with traditional PLF, interbody fusion with posterior approach, and circumferential fusion is still contested.
METHODS: The ACS NSQIP database was used to identify 24,228 patients who underwent either a single-level PLF, single-level PLIF/TLIF, or combined single-level PLF+PLIF/TLIF between 2014 and 2017. To control for potential confounding variables, exact matching was used to pair individuals from each treatment group based on several factors, including sex, age, body mass index, various comorbidities, and American Society of Anesthesiologists classification. After appropriate matching, the rate of various short-term outcome measures and complications were compared between the three treatment groups.
RESULTS: After exact matching, 13,251 patients were included in the final analysis. The rates of non-home discharge, overall surgical complications, and bleeding requiring transfusion were significantly lower in the PLF group and PLIF/TLIF group relative to the PLF+PLIF/TLIF group (P < 0.001 for all comparisons). The rate of deep venous thrombosis was lower in the PLIF/TLIF group relative to the PLF group (P = 0.006). There were no significant differences in other medical complications, unplanned readmission, reoperation, or return to the OR between any of the treatment groups.
CONCLUSIONS: The combination of single-level PLF+PLIF/TLIF is associated with higher rates of short-term complications relative to either single-level PLF or PLIF/TLIF alone. The associated risks of this therapy should be considered when considering surgical management for lumbar disease. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2020        PMID: 32796465     DOI: 10.1097/BRS.0000000000003615

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  30-Day outcomes analysis of surgical management of radial head fractures comparing radial head arthroplasty to open reduction internal fixation.

Authors:  Joshua P Weissman; Mark A Plantz; Erik B Gerlach; Colin K Cantrell; Bennet Butler
Journal:  J Orthop       Date:  2022-02-12

Review 2.  [Reasons analysis on unplanned reoperation of degenerative lumbar spine diseases].

Authors:  Ruihuan Du; Zhonghai Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-12-15

3.  The effect of posterior lumbar dynamic fixation and intervertebral fusion on paraspinal muscles.

Authors:  Geng-Xiong Lin; Yan-Ming Ma; Yong-Chun Xiao; Dian Xiang; Jian-Xian Luo; Guo-Wei Zhang; Zhi-Sheng Ji; Hong-Sheng Lin
Journal:  BMC Musculoskelet Disord       Date:  2021-12-20       Impact factor: 2.362

4.  Increased 30-Day Postoperative Readmission and Medical Complication Rates Among Patients 65 Years and Older Following Arthroscopic Rotator Cuff Repair.

Authors:  Mark A Plantz; Scott A Wu; Erik B Gerlach; Nicholas C Arpey; Peter R Swiatek; John J Carney; Vehniah K Tjong
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-05-24

5.  Determining the incidence and risk factors for short-term complications following distal biceps tendon repair.

Authors:  Cody Goedderz; Mark A Plantz; Erik B Gerlach; Nicholas C Arpey; Peter R Swiatek; Colin K Cantrell; Michael A Terry; Vehniah K Tjong
Journal:  Clin Shoulder Elb       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.